Earlier this year, Andrea James – the IR Impact Award-winning former investor relations lead at Axon – talked to us about taking a sabbatical from investor relations as she sought a new role. Having taken time to herself, then taken time think about what her next move might look like, she manifested a CFO position at a small cap. That small cap is Nasdaq-listed precision diagnostics firm Oncocyte.
Here James talks to IR Impact about the skills you need to make the move from IR to CFO, what she looks for from her advisers and why stock-picking and finance . . .
Enjoy unlimited access to this, all deep dives and more – for free!
Log in or create your free My IR – Essentials account to:
- Get unlimited access to 50+ IR deep dives and best practice reports
- Benchmark your IR program instantly with our new tool
- Explore 100+ news analyses plus our exclusive CFO interviews
- Save favorites and get personalized content on your dashboard
- Enjoy 10% off all IR forums
